产品标题 产品货号 产品规格 厂家
Human POU class 2 homeobox 1 (POU2F1) from ORIGENE TECHNOLOGIESTP30859920 ugORIGENE TECHNOLOGIES
Human POU class 2 homeobox 3 (POU2F3) from ORIGENE TECHNOLOGIESTP31096920 ugORIGENE TECHNOLOGIES
Human POU class 3 homeobox 2 (POU3F2) from ORIGENE TECHNOLOGIESTP30533020 ugORIGENE TECHNOLOGIES
Human POU class 3 homeobox 4 (POU3F4) from ORIGENE TECHNOLOGIESTP32164520 ugORIGENE TECHNOLOGIES
Human POU class 4 homeobox 1 (POU4F1) from ORIGENE TECHNOLOGIESTP31628420 ugORIGENE TECHNOLOGIES
Human POU class 6 homeobox 2 (POU6F2) from ORIGENE TECHNOLOGIESTP32419220 ugORIGENE TECHNOLOGIES
Human POU class 4 homeobox 2 (POU4F2) from ORIGENE TECHNOLOGIESTP31596220 ugORIGENE TECHNOLOGIES
Human POU class 5 homeobox 1 (POU5F1/OCT4), transcript variant 2, full length from ORIGENE TECHNOLOGIESTP76093850 ugORIGENE TECHNOLOGIES
Human POU class 5 homeobox 1 (POU5F1), transcript variant 1 from ORIGENE TECHNOLOGIESTP31199820 ugORIGENE TECHNOLOGIES
Human POU class 6 homeobox 1 (POU6F1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30859820 ugORIGENE TECHNOLOGIES
Human POU class 6 homeobox 2 (POU6F2), transcript variant 2. from ORIGENE TECHNOLOGIESTP32852120 ugORIGENE TECHNOLOGIES
Human POZ (BTB) and AT hook containing zinc finger 1 (PATZ1), transcript variant 4, full length from ORIGENE TECHNOLOGIESTP76013950 ugORIGENE TECHNOLOGIES
Human POZ (BTB) and AT hook containing zinc finger 1 (PATZ1), transcript variant 1, full length from ORIGENE TECHNOLOGIESTP76094550 ugORIGENE TECHNOLOGIES
Human PPPDE peptidase domain containing 1 (PPPDE1) from ORIGENE TECHNOLOGIESTP30252420 ugORIGENE TECHNOLOGIES
Human PPPDE peptidase domain containing 2 (PPPDE2) from ORIGENE TECHNOLOGIESTP31089220 ugORIGENE TECHNOLOGIES
Human p21 protein (Cdc42/Rac)-activated kinase 1 (PAK1), transcript variant 1 from ORIGENE TECHNOLOGIESTP32594720 ugORIGENE TECHNOLOGIES
Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 1 from ORIGENE TECHNOLOGIESTP30230220 ugORIGENE TECHNOLOGIES
Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2 from ORIGENE TECHNOLOGIESTP30684720 ugORIGENE TECHNOLOGIES
Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 3 from ORIGENE TECHNOLOGIESTP31709720 ugORIGENE TECHNOLOGIES
Human p21 protein (Cdc42/Rac)-activated kinase 7 (PAK7), transcript variant 2 from ORIGENE TECHNOLOGIESTP31417320 ugORIGENE TECHNOLOGIES
Human PQ loop repeat containing 1 (PQLC1) from ORIGENE TECHNOLOGIESTP30431020 ugORIGENE TECHNOLOGIES
Human PRA1 domain family, member 2 (PRAF2) from ORIGENE TECHNOLOGIESTP30291020 ugORIGENE TECHNOLOGIES
Human PRAME family member 10 (PRAMEF10) from ORIGENE TECHNOLOGIESTP31134920 ugORIGENE TECHNOLOGIES
Human PRAME family member 19 (PRAMEF19) from ORIGENE TECHNOLOGIESTP31370420 ugORIGENE TECHNOLOGIES
Human PR domain containing 11 (PRDM11) from ORIGENE TECHNOLOGIESTP32291120 ugORIGENE TECHNOLOGIES
Human PR domain containing 12 (PRDM12) from ORIGENE TECHNOLOGIESTP31143420 ugORIGENE TECHNOLOGIES
Human PR domain containing 14 (PRDM14), full length from ORIGENE TECHNOLOGIESTP76119750 ugORIGENE TECHNOLOGIES
Human PR domain containing 16 (PRDM16), transcript variant 1 from ORIGENE TECHNOLOGIESTP31402620 ugORIGENE TECHNOLOGIES
Human PR domain containing 7 (PRDM7), transcript variant 2 from ORIGENE TECHNOLOGIESTP31467820 ugORIGENE TECHNOLOGIES
Human PR domain containing 2, with ZNF domain (PRDM2), transcript variant 4 from ORIGENE TECHNOLOGIESTP32771520 ugORIGENE TECHNOLOGIES
Human pre-B-cell leukemia homeobox 1 (PBX1) from ORIGENE TECHNOLOGIESTP31094420 ugORIGENE TECHNOLOGIES
Human pre-B-cell leukemia homeobox 2 (PBX2) from ORIGENE TECHNOLOGIESTP31025020 ugORIGENE TECHNOLOGIES
Human pre-B-cell leukemia homeobox 4 (PBX4), transcript variant 1, full length from ORIGENE TECHNOLOGIESTP76089750 ugORIGENE TECHNOLOGIES
Human pre-B lymphocyte 3 (VPREB3) from ORIGENE TECHNOLOGIESTP30466220 ugORIGENE TECHNOLOGIES
Human preferentially expressed antigen in melanoma (PRAME), transcript variant 3 from ORIGENE TECHNOLOGIESTP76046450 ugORIGENE TECHNOLOGIES
Human preferentially expressed antigen in melanoma (PRAME), transcript variant 4 from ORIGENE TECHNOLOGIESTP30787420 ugORIGENE TECHNOLOGIES
Human preferentially expressed antigen in melanoma (PRAME), transcript variant 5, full length from ORIGENE TECHNOLOGIESTP76091350 ugORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6031815x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6031825x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6031835x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6031845x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6031855x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6039475x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6040625x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6040735x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6044825x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6066435x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6066425x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6066445x5umORIGENE TECHNOLOGIES
Human Prostate; Hyperplasia of prostate from ORIGENE TECHNOLOGIESCS6066475x5umORIGENE TECHNOLOGIES
 |< < 2305 2306 2307 2308 2309 2310 2311 2312 2313 > >| 第 2313/6274 页